Categories Selected Articles Factor in Eli Lilly weight-loss drug could help treat certain eating disorders, study finds Post author By Mike Nova Post date November 18, 2025 Researchers reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the “reward center” of the brain. ← Judge formally approves opioid settlement for Purdue Pharma and Sackler family members who own the company → Millions Issued Guidance for Potential Chinese Invasion